James M Mock insider trades: Moderna (MRNA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | MRNA | ↓ Sell | 34,836 | $134.49 | $4.7M | Direct | Sep 14, 2026 (4d) |
| Nov 29, 2024 | MRNA | ↓ Sell | 1,420 | $42.79 | $61K | Direct | Dec 2, 2024 (3d) |
| Oct 7, 2024 | MRNA | ↓ Sell | 715 | $60.12 | $43K | Direct | Oct 8, 2024 (1d) |
| Aug 29, 2024 | MRNA | ↓ Sell | 162 | $78.03 | $13K | Direct | Aug 30, 2024 (1d) |
| Aug 28, 2024 | MRNA | ↓ Sell | 1,321 | $79.39 | $105K | Direct | Aug 29, 2024 (1d) |
| Jul 8, 2024 | MRNA | ↓ Sell | 689 | $118.24 | $81K | Direct | Jul 9, 2024 (1d) |
| Jun 3, 2024 | MRNA | ↓ Sell | 691 | $140.72 | $97K | Direct | Jun 4, 2024 (1d) |
| May 29, 2024 | MRNA | ↓ Sell | 183 | $144.50 | $26K | Direct | May 30, 2024 (1d) |
| May 28, 2024 | MRNA | ↓ Sell | 648 | $162.47 | $105K | Direct | May 29, 2024 (1d) |
| Apr 8, 2024 | MRNA | ↓ Sell | 705 | $101.93 | $72K | Direct | Apr 9, 2024 (1d) |
| Feb 29, 2024 | MRNA | ↓ Sell | 647 | $94.57 | $61K | Direct | Mar 1, 2024 (1d) |
| Jan 8, 2024 | MRNA | ↓ Sell | 772 | $109.75 | $85K | Direct | Jan 9, 2024 (1d) |
| Oct 6, 2023 | MRNA | ↓ Sell | 2,858 | $102.50 | $293K | Direct | Oct 10, 2023 (4d) |
| Jun 24, 2022 | PKI | ↓ Sell | 5,025 | $145.49 | $731K | Direct | Jun 27, 2022 (3d) |
| Sep 20, 2021 | PKI | ↓ Sell | 6,080 | $184.87 | $1.1M | Direct | Sep 21, 2021 (1d) |
| Oct 2, 2020 | PKI | ↓ Sell | 5,623 | $124.41 | $700K | Direct | Oct 5, 2020 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRNA insiders
Open-market trades in the last 12 months
About James M Mock's insider trades
James M Mock is Chief Financial Officer at Moderna (MRNA). Since Oct 2, 2020, James has reported no open-market purchases and 16 sales worth $8.3M on SEC Form 4. In the last 12 months: 1 sale ($4.7M).
Their filings also include option exercises (35 filings), shares withheld for taxes (28 filings), grants and awards (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.